WT6-17313-05562
5 vaccinations
1 coded response
36 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 208 / MD
- Registered
- 2021-04-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-13
Dose 1 — Pfizer-BioNTech
-
2021-04-14
Registered in v-safe
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-18
- 2021-04-19
- 2021-04-21
- 2021-04-27
- 2021-05-06
-
2021-05-12
Dose 2 — Pfizer-BioNTech
- 2021-05-12
-
2021-05-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Muscle or body achesAdult check-in
- 2021-05-14
- 2021-05-15
- 2021-05-16
- 2021-05-17
- 2021-05-18
- 2021-05-19
- 2021-05-26
- 2021-06-02
- 2021-06-09
- 2021-06-16
- 2021-06-23
- 2021-08-13
- 2021-11-11
-
2021-12-21
Dose 3 — Pfizer-BioNTech
- 2022-05-12
-
2022-05-22
Dose 4 — Pfizer-BioNTech
-
2022-09-12
Dose 5 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-13
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-09-16
- 2022-09-17
- 2022-09-18
- 2022-09-19
- 2022-09-26
- 2022-10-03
- 2022-10-10
- 2022-10-17
- 2022-10-24
-
2022-12-12
Survey response — 3 months, dose 5MedDRA: Exposure to SARS-CoV-2, Malaise — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID, not diagnosed by doctor, but my daughter and husband both tested positive and I was symptomatic.MedDRA releases: 2024-11 · check-in free text available
- 2023-03-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-13 | Pfizer-BioNTech | |
| 2 | 2021-05-12 | Pfizer-BioNTech | |
| 3 | 2021-12-21 | Pfizer-BioNTech | No |
| 4 | 2022-05-22 | Pfizer-BioNTech | No |
| 5 | 2022-09-12 | Pfizer-BioNTech | Flu |
Free text
Release 12 — 3 months, dose 5
Symptoms: COVID, not diagnosed by doctor, but my daughter and husband both tested positive and I was symptomatic.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release